Position in PFE
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$1,568,498
-$519,558 QoQ
Shares Held
65,137
-12.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#1,075
of 2,821 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Intrua Financial, LLC holds $17,604,029 across 11 Drug Manufacturers - General names. PFE ranks #5 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
19,859 | $4,997,318 | |
| 2 | LLY |
ELI LILLY & Co
|
2,244 | $2,691,521 | |
| 3 | JNJ |
Johnson & Johnson
|
10,446 | $2,652,970 | |
| 4 | AMGN |
Amgen Inc
|
5,070 | $1,835,948 | |
| 5 | PFE |
Pfizer Inc
This page
|
65,137 | $1,568,498 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,442 | $1,120,248 | |
| 7 | GSK |
GSK plc
|
16,873 | $884,482 | |
| 8 | MRK |
Merck & Co., Inc.
|
6,787 | $872,129 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,568,498 | 65,137 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $2,088,056 | 74,361 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $1,906,891 | 76,582 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,975,184 | 77,519 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $1,873,024 | 77,270 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,986,453 | 78,392 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $1,770,850 | 66,749 | Shares | Sole | 2025-05-28 | |
| 2024-09-30 | $1,767,250 | 61,066 | Shares | Sole | 2025-05-28 | |
| 2024-06-30 | $1,804,849 | 64,505 | Shares | Sole | 2025-05-28 | |
| 2024-03-31 | $1,825,866 | 65,797 | Shares | Sole | 2025-05-28 | |
| 2023-12-31 | $1,780,920 | 61,859 | Shares | Sole | 2025-05-28 | |
| 2023-09-30 | $2,208,591 | 66,584 | Shares | Sole | 2025-05-28 | |
| 2023-06-30 | $2,929,888 | 79,877 | Shares | Sole | 2025-02-13 | |
| 2023-03-31 | $2,457,588 | 60,235 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,139,833 | 41,761 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $1,587,962 | 36,288 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,195,715 | 41,879 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $2,007,744 | 38,782 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,960,223 | 33,196 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,593,692 | 37,054 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $930,676 | 23,766 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $841,006 | 23,213 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $488,174 | 13,262 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $460,694 | 12,553 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $587,946 | 17,980 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||